Conference paper
AN AUDIT TO COMPARE PATIENT FACTORS (AGE, SEX, SOCIAL BACKGROUND & ASSOCIATED PHYSICAL DIAGNOSES) IN PEOPLE WITH REFRACTORY DEPRESSION IN A BEDFORDSHIRE COMMUNITY MENTAL HEALTH TEAM (BCMHT) BEING AUGMENTED WITH (A) MIRTAZEPINE, (B) ATYPICAL ANTIPSYCHOTICS OR (C) BOTH
Clare Holt
; Foundation Programme East Anglian Deanery, UK
Sophie Butler
; Foundation Programme East Anglian Deanery, UK
Mark Agius
; South Essex Partnership University Foundation Trust, UK; Department of Psychiatry, University of Cambridge, UK
Rashid Zaman
; South Essex Partnership University Foundation Trust, UK; Department of Psychiatry, University of Cambridge, UK
Abstract
In recent years, there has been particular interest in the use of augmentation as a strategy for the treatment of refractory
depression. The purpose of this audit was to define patient factors among people receiving augmentation therapy with either
mirtazepine or atypical antipsychotics. We searched an anonymised database of patients and identified those with receiving
augmentation with mirtazepine (group A), atypical antipsychotics (group B) or both (group C). The audit reveals some interesting
differences in patient factors between the three groups. Knowledge about such differences is useful in practical terms because it
allows doctors in the BCMHT to target therapy for different patients towards their specific needs. However, the audit cannot explain
the underlying reasons for these differences.
Keywords
augmentation; mirtazepine; antipsychotics; drug abuse; alcohol abuse
Hrčak ID:
264851
URI
Publication date:
1.9.2011.
Visits: 185 *